The Case for 340B Done Right
MedCity News
MARCH 30, 2025
Its critical that healthcare organizations delivering on the programs promise not be torpedoed by the bad actors The post The Case for 340B Done Right appeared first on MedCity News.
Sun.Mar 30, 2025
147 
ACC 2025: Oral Semaglutide Reduces Cardiovascular Events by 14% at 4 Years
Pharmacy Times
MARCH 30, 2025
The trial is the first to test the cardiovascular benefits of an oral glucagon-like peptide-1 (GLP-1) agonist.
Join 8,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
What’s Private Equity’s Impact on Intellectual and Developmental Disability Services?
MedCity News
MARCH 30, 2025
A new report from the Private Equity Stakeholder Project reveals that private equity firms have been increasingly acquiring intellectual and developmental disability providers and implementing cost-cutting strategies that reduce care quality. The post Whats Private Equitys Impact on Intellectual and Developmental Disability Services? appeared first on MedCity News.
ACC 2025: Intravenous Iron Safe, but Results in Mixed Findings for Patients With Heart Failure
Pharmacy Times
MARCH 30, 2025
Patients in the treatment group had a 21% lower risk of cardiovascular death or first heart failure hospitalization overall, but the between-group difference did not meet the threshold for statistical significance for this primary end point.
State of AI in Sales & Marketing 2025
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
PCR Comes to the Home With FDA Authorization of Visby’s OTC Sexual Health Test
MedCity News
MARCH 30, 2025
The FDA granted marketing authorization to a Visby Medical at-home PCR test for three common sexually transmitted infections. The Visby test yields results in about 30 minutes. The post PCR Comes to the Home With FDA Authorization of Visbys OTC Sexual Health Test appeared first on MedCity News.
Sign up to get articles personalized to your interests!
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
More Trending
Unlocking the Potential: Medication Assisted Therapies for Opioid Substance Use Disorder in Correctional Settings
MedCity News
MARCH 30, 2025
To reduce overdose rates in the U.S., leaders must recognize the impact of medication-assisted treatment in correctional facilities. The post Unlocking the Potential: Medication Assisted Therapies for Opioid Substance Use Disorder in Correctional Settings appeared first on MedCity News.
FINEARTS-HF Analysis: How Liver Biomarkers Influence Heart Failure Risk
Pharmacy Times
MARCH 30, 2025
Jawad Butt, MD, offers insight into his analysis of the FINEARTS-HF trial.
Two Chairs Expands Mental Health Services to 19 More States
MedCity News
MARCH 30, 2025
Two Chairs, which offers hybrid behavioral health care, expanded its presence from three states to 22 states. This expansion gives millions of people access to therapy services, as Two Chairs services are now available to 75% of the U.S. population. The post Two Chairs Expands Mental Health Services to 19 More States appeared first on MedCity News.
Let's personalize your content